Pune, India, Feb. 02, 2021 (GLOBE NEWSWIRE) -- The global DBS Devices Market size is expected to reach USD 1,676.8 million by 2026, exhibiting a CAGR of 11.6% during the forecast period. According to the report, published by Fortune Business Insights in a report, states that the value of the market stood at USD 696.4 million in 2018.
The growing awareness among the population concerning various neurological ailments will be a crucial factor in accelerating the deep brain stimulation (DBS) devices market revenue during the forecast period. In addition, the increasing cases of epilepsy around the world will fuel demand for deep brain stimulation devices in the forthcoming years.
According to the World Health Organization, Epilepsy is a chronic non-communicable disease of the brain that affects people of all ages. Around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. In addition, the increasing prevalence of neurological diseases in low and middle-income countries will propel the growth of the market in the foreseeable future. For instance, as per the World Health Organization survey, nearly 80% of people with epilepsy live in low- and middle-income countries.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/deep-brain-stimulation-dbs-devices-market-100559
INDUSTRY DEVELOPMENTS:
- February 2019: Medtronic announced the launch of Deep Brain Stimulation (DBS) for medically-refractory epilepsy in the U.S. Such novel product launch will assist the company to broaden its customer base as well as generate more revenue.
- January 2019: Boston Scientific Corporation has launched the Vercise Gevia and Vercise Primary Cell (PC) Deep Brain Stimulation (DBS) Systems featuring the Vercise Cartesia Directional Lead. This new feature technology is designed to allow specialists and physicians to control the shape, range, direction and position of electrical lead stimulation for the treatment of neurological diseases through highly-personalized therapy.
- January 2017: Abbott announced the acquisition of St. Jude Medical, Inc.; one of the leading medical device company. Such acquisition enabled the company to expand its medical device portfolio in the DBS Devices Market.
Click here to get the short-term and long-term impacts of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/deep-brain-stimulation-dbs-devices-market-100559
Unveiling of Vercise Gevia™ Deep Brain Stimulation Systems to Benefit in Revenue Generation
Boston Scientific Corporation, a manufacturer of medical devices used in interventional medical specialties, including interventional radiology and interventional cardiology launched the Vercise™ Primary Cell (PC) and Vercise Gevia™ Deep Brain Stimulation (DBS) Systems featuring the Vercise Cartesia Directional Lead.
The new ground breaking systems feature technology designed to allow physicians to control the range, shape, position and direction of electrical stimulation to treat the symptoms of Parkinson's disease (PD) through highly-personalized therapy and are approved by the U.S. Food and Drug Administration (FDA). The launch of the new systems by Boston Scientific Corporation will boost the DBS Devices Market trends during the forecast period owing to the engineered systems, which allows customized stimulations compared to other devices.
Furthermore, Maulik Nanavaty, senior vice president and president, Neuromodulation, Boston Scientific said in a statement “Our newest generation Vercise Directional DBS Systems are supported by years of clinical data and real-world experience on the advantages of directionality and offer programming software with features that give physicians the ability to tailor therapy for individual patient needs.”
Quick Buy - DBS Devices Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100559
Rising Patient Pool to Encourage Growth in Asia Pacific
Asia Pacific is expected to witness the highest growth in the market owing to the growing demand in countries such as Japan, China and India. The increasing disposable income leading to higher healthcare expenditure will also aid growth in the region. Furthermore, the growing awareness regarding various neurological conditions such as epilepsy, essential tremors and Parkinson’s disorder will fuel demand for DBS in Asia Pacific.
The increasing number of medical settings such as specialty clinics and multispecialty hospitals is also a major factor stimulating growth in the region. The market in North America stood at USD 323.4 million in 2018 and is expected to flourish rapidly. The presence of major players in the region will uplift the DBS Devices Market share.
Some of the Major Companies in the DBS Devices Market:
- Abbott (ST. JUDE MEDICAL)
- Medtronic
- Boston Scientific Corporation
- Beijing PINS Medical Co., Ltd.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/deep-brain-stimulation-dbs-devices-market-100559
Global DBS Devices Market Segmentations:
By Product Type
• Dual Channel Deep Brain stimulators
• Single Channel Deep Brain Stimulators
By Application
• Parkinson's Disease
• Dystonia
• Essential Tremor
• Others
By End User
• Hospitals
• Specialty Clinics
• Others
By Geography
• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East and Africa ( South Africa, GCC, and Rest of the Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/deep-brain-stimulation-dbs-devices-market-100559
Have a Look at Related Reports:
Regenerative Medicine Market Share and Global Trend By By Product (Cell Therapy, Gene Therapy, Tissue Engineering, Platelet Rich Plasma), By Application (Orthopaedics, Wound Care, Oncology), By Distribution Channel (Hospitals, Clinics) & Geography Forecast till 2026
Hyaluronic Acid Based Dermal Fillers Market Share and Global Trend By Crosslinking Type (Monophasic, Biphasic), By Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/ Fullness), By End User(Specialty & Dermatology Clinics, Hospitals & Clinics) and Geography Forecast till 2026
Botulinum Toxin Market Share and Global Trend By Application (Therapeutics, Aesthetics), By End User(Specialty & Dermatology Clinics, Hospitals & Clinics), By Type(Botulinum Toxin Type A, Botulinum Toxin Type B) and Geography Forecast till 2026
Next-Generation Sequencing (NGS) Market Share and Global Trend By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Geography Forecast till 2026
U.S. Biosimilars Market Share and Global Trend By Drug Class (Filgrastim & Pegfilgrastim, Monoclonal Antibodies, Others), By Disease Indication (Cancer, Autoimmune Diseases, Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/deep-brain-stimulation-dbs-devices-market-9578